TW202426041A - 包含經結合之莢膜醣抗原的免疫原組合物及其用途 - Google Patents

包含經結合之莢膜醣抗原的免疫原組合物及其用途 Download PDF

Info

Publication number
TW202426041A
TW202426041A TW112144898A TW112144898A TW202426041A TW 202426041 A TW202426041 A TW 202426041A TW 112144898 A TW112144898 A TW 112144898A TW 112144898 A TW112144898 A TW 112144898A TW 202426041 A TW202426041 A TW 202426041A
Authority
TW
Taiwan
Prior art keywords
immunogenic compositions
capsular saccharide
saccharide antigens
conjugated capsular
prevnar
Prior art date
Application number
TW112144898A
Other languages
English (en)
Inventor
凱薩琳 艾力克斯
安納麗莎 西柏爾 安德森
畢什瓦 拉傑 賀圖瓦爾
則誠 陳
考希克 杜塔
凱特林 高拉格
建新 顧
伊西斯 坎恩夫斯基
進煥 金
賈斯汀 凱斯 摩蘭
蘇德漢 辛格
納文 蘇倫卓安
艾柏席賽克 拉文卓 法塔克
雨迎 楊
Original Assignee
美商輝瑞大藥廠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商輝瑞大藥廠 filed Critical 美商輝瑞大藥廠
Publication of TW202426041A publication Critical patent/TW202426041A/zh

Links

Abstract

本發明係關於包含經結合之肺炎鏈球菌( <i>Streptococcus pneumoniae</i>)莢膜醣抗原(醣結合物)之新穎免疫原組合物及其用途。本發明之免疫原組合物將通常包含至少一種來自未在Prevnar、Synflorix及/或Prevnar 13中發現的肺炎鏈球菌血清型之醣結合物。本發明亦關於使用該等新穎免疫原組合物對人類個體，尤其嬰兒及老年人進行疫苗接種以抵抗肺炎鏈球菌感染。
TW112144898A 2022-11-22 2023-11-21 包含經結合之莢膜醣抗原的免疫原組合物及其用途 TW202426041A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/384,626 2022-11-22
US63/593,565 2023-10-27

Publications (1)

Publication Number Publication Date
TW202426041A true TW202426041A (zh) 2024-07-01

Family

ID=

Similar Documents

Publication Publication Date Title
MX2021015775A (es) Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados, kits que las comprenden y sus usos.
WO2015110941A3 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
EP2402025A3 (en) Vaccine
Austrian Prevention of pneumococcal infection by immunization with capsular polysaccharides of Streptococcus pneumoniae: current status of polyvalent vaccines
BRPI0407101A (pt) Vacinas meningocócicas mucosais
WO2009000825A3 (en) Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
BR0009166A (pt) Vacina
FI3244917T3 (fi) Immunogeenisiä koostumuksia pneumokokkirokotteissa käytettäväksi
ES2151597T3 (es) Composiciones inmunogenicas de polisacaridos estreptococcicos del grupo a y procedimientos.
WO2020131763A3 (en) Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
WO2004041157A3 (en) Group b streptococcus vaccine
WO2000062801A3 (en) Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
WO2022101745A3 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
Penn et al. Antibody responses in adult volunteers to pneumococcal polysaccharide types 19F and 19A administered singly and in combination
TW202426041A (zh) 包含經結合之莢膜醣抗原的免疫原組合物及其用途
WO2024110839A3 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
MX2023005221A (es) Composiciones inmunogenicas para uso en vacunas neumococicas.
Fernsten et al. 13-valent pneumococcal conjugate vaccine immune sera protects against pneumococcal serotype 1, 3, and 5 bacteremia in a neonatal rat challenge model
WO2021044436A3 (en) Immunogenic compositions against enteric diseases and methods for its preparation thereof
Ling et al. Membrane component of Shigella flexneri and their relationship to bacteria antigenicities and virulences
Frasch et al. Induction of group 17 specific antibodies by pneumococcal type 17F and 17A polysaccharide vaccines
TH95746A (th) วัคซีนมัลติวาเลนท์ Streptococcus pneumoniae คอนจูเกต ที่ประกอบรวมด้วย ซีโรไทพ์ 22F แซคคาไรด์ คอนจูเกต